About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 374 record(s)
Req # A-2021-000220
Adverse Reaction Reports (AERs). Report numbers: 000934532, E2B_01661781, E2B_03022322, 000933138, 000933280, E2B_03517841, E2B_03637836, E2B_03639641, E2B_03657534, E2B_03665624, E2B_03668209, E2B_03692076, E2B_03692077, E2B_03697466, 000933423, 000933293, 000933697, E2B_03565507, E2B_03634008, E2B_03661254.Organization: Health Canada
September 2021
Req # A-2021-000246
As to human resources under the Health Canada’s ATIP department, the average staff turnover annually (by percentage) and the average amount of time staff was employed, reason(s) for leaving when an exit interview was conducted, and the number of employees who did not give a specified reason (they did partake in an exit interview or other). Date Range: January 1, 2017 to May 17, 2021.Organization: Health Canada
September 2021
Req # A-2021-000267
Documents that show the ingredients used to manufacture and sterilize the nasal swab in the Swab and Phosphate Buffered Saline Test Kit.Organization: Health Canada
September 2021
Req # A-2021-000286
Adverse Drug Reaction (ADR) for Mictoryl (propiverine hydrochloride). Report number: E2B_03204835.Organization: Health Canada
September 2021
Req # A-2021-000306
Adverse Reaction Reports (AERs) for Zostavax II. Report numbers: E2B_01333350, E2B_01438894, E2B_01440660, E2B_01497636.Organization: Health Canada
September 2021
Req # A-2021-000310
Adverse Reaction Reports (AERs) for Pantoprazole sodium. Report numbers: E2B_03769405, E2B_03729839, E2B_03732541, E2B_03723458, E2B_03742382, E2B_03747427, E2B_03765922, E2B_03720802, E2B_03764326, 936581. AERs for Pantoprazole magnesium. Report numbers: E2B_03757188, E2B_03758098. AERs for Amphetamine. Report numbers: E2B_03728613, E2B_03709420, 934844, 935569. AERs for Mezavant. Report numbers: 936025, E2B_03718635.Organization: Health Canada
September 2021
Req # A-2021-000321
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104168-654, Establishing the Office of the Chief Data Officer.Organization: Health Canada
September 2021
Req # A-2021-000333
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-104611-600, Response to subsection 37(1) Letter from the Information Commissioner.Organization: Health Canada
September 2021
Req # A-2021-000358
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-101485-157.Organization: Health Canada
September 2021
Req # A-2021-000377
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-102837-585.Organization: Health Canada
September 2021